2016 ACBS Landline-Cellphone Combined Prevalence Tables
BRFSS Asthma Call-back Survey Prevalence TABLE 8b. Estimated percent advised to make environmental changes for active1 and inactive2 asthma status among adults3 ever diagnosed with asthma by state/territory – BRFSS Asthma Call-back Survey, United States, 2016.
State/Territory | Active | Inactive | ||||||
---|---|---|---|---|---|---|---|---|
Sample size± |
% | SE§ | 95% CI† | Sample size |
% | SE | 95% CI | |
Arizona | 357 | 35.1 | 4.6 | (26.1 – 44.1) | 98 | N/A | N/A | (N/A – N/A) |
California | 263 | 35.8 | 3.9 | (28.2 – 43.4) | 104 | 27.9 | 7.1 | (14.0 – 41.8) |
Connecticut | 316 | 37.2 | 4.1 | (29.2 – 45.2) | 92 | 18.0 | 4.9 | (8.4 – 27.6) |
Florida | 978 | 27.8 | 3.2 | (21.5 – 34.1) | 279 | 21.5 | 5.0 | (11.7 – 31.3) |
Georgia | 157 | 35.6 | 5.5 | (24.8 – 46.4) | 58 | N/A | N/A | (N/A – N/A) |
Hawaii | 246 | 30.9 | 4.8 | (21.5 – 40.3) | 112 | 16.6 | 4.5 | (7.8 – 25.4) |
Illinois | 176 | 35.6 | 5.2 | (25.4 – 45.8) | 57 | N/A | N/A | (N/A – N/A) |
Indiana | 468 | 41.9 | 3.6 | (34.8 – 49.0) | 86 | 32.7 | 7.5 | (18.0 – 47.4) |
Iowa | 189 | 33.5 | 5.1 | (23.5 – 43.5) | 59 | N/A | N/A | (N/A – N/A) |
Kansas | 387 | 37.6 | 3.6 | (30.5 – 44.7) | 114 | 31.5 | 5.9 | (19.9 – 43.1) |
Maine | 577 | 43.5 | 3.4 | (36.8 – 50.2) | 152 | 28.2 | 5.9 | (16.6 – 39.8) |
Massachusetts | 218 | 36.1 | 4.5 | (27.3 – 44.9) | 49 | N/A | N/A | (N/A – N/A) |
Michigan | 661 | 38.7 | 2.6 | (33.6 – 43.8) | 176 | 25.0 | 4.1 | (17.0 – 33.0) |
Minnesota | 604 | 29.3 | 2.3 | (24.8 – 33.8) | 155 | 23.0 | 3.9 | (15.4 – 30.6) |
Missouri | 278 | 34.5 | 5.5 | (23.7 – 45.3) | 56 | N/A | N/A | (N/A – N/A) |
Montana | 194 | 32.2 | 5.5 | (21.4 – 43.0) | 64 | N/A | N/A | (N/A – N/A) |
Nebraska | 472 | 24.2 | 3.5 | (17.3 – 31.1) | 147 | 36.4 | 7.3 | (22.1 – 50.7) |
Nevada | 158 | 34.5 | 5.9 | (22.9 – 46.1) | 47 | N/A | N/A | (N/A – N/A) |
New Hampshire | 218 | 44.0 | 5.1 | (34.0 – 54.0) | 62 | 38.4 | 9.1 | (20.6 – 56.2) |
New Jersey | 293 | 24.6 | 3.8 | (17.2 – 32.0) | 68 | 37.5 | 9.9 | (18.1 – 56.9) |
New Mexico | 209 | 32.7 | 5.2 | (22.5 – 42.9) | 59 | N/A | N/A | (N/A – N/A) |
New York | 461 | 31.0 | 4.0 | (23.2 – 38.8) | 124 | 33.4 | 9.4 | (15.0 – 51.8) |
Ohio | 451 | 33.1 | 3.8 | (25.7 – 40.5) | 122 | 16.9 | 4.8 | (7.5 – 26.3) |
Oklahoma | 153 | 31.1 | 5.5 | (20.3 – 41.9) | 44 | N/A | N/A | (N/A – N/A) |
Oregon | 165 | 42.5 | 4.4 | (33.9 – 51.1) | 64 | 16.7 | 4.8 | (7.3 – 26.1) |
Pennsylvania | 262 | 30.3 | 4.0 | (22.5 – 38.1) | 77 | 17.7 | 5.1 | (7.7 – 27.7) |
Rhode Island | 189 | 30.8 | 5.4 | (20.2 – 41.4) | 46 | 34.3 | 10.0 | (14.7 – 53.9) |
Texas | 375 | 31.2 | 4.7 | (22.0 – 40.4) | 120 | N/A | N/A | (N/A – N/A) |
Utah | 335 | 26.9 | 3.4 | (20.2 – 33.6) | 128 | 18.4 | 5.2 | (8.2 – 28.6) |
Vermont | 245 | 44.6 | 4.7 | (35.4 – 53.8) | 77 | 25.7 | 6.5 | (13.0 – 38.4) |
Wisconsin | 220 | 35.6 | 4.7 | (26.4 – 44.8) | 60 | N/A | N/A | (N/A – N/A) |
Puerto Rico | 323 | 44.3 | 4.3 | (35.9 – 52.7) | 95 | 34.8 | 6.9 | (21.3 – 48.3) |
32 states / area | 10,598 | 33.8 | 1.0 | (31.8 – 35.8) | 3,051 | 24.8 | 2.0 | (20.9 – 28.7) |
Median | 34.5 | 26.8 | ||||||
Range | 24.2-44.6 | 16.6-38.4 |
1 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
2 Reported none of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
3 Aged ≥ 18 years
± Landline and cell phone combined sample size excludes “DK/Refused”
§ Standard error
† Confidence interval
N/A: Estimate not available (N/A) if the unweighted sample size for the denominator was < 50 or if the relative standard error was > 0.30
Link for Summary Data Quality Report: https://www.cdc.gov/brfss/acbs/2016/pdf/sdq_report_acbs_16-508.pdfpdf icon
Page last reviewed: February 19, 2020